BioCentury | Jul 25, 2018
Distillery Therapeutics

Infectious disease

...include testing miR-138 or its mimics in mouse models of other bacterial lung infections. TARGET/MARKER/PATHWAY: MicroRNA-138 (miR-138)...
...Third Military Medical University, Chongqing, Sichuan, China email: hellojjx@126.com Sandi Wong Third Military Medical University University of North Dakota MicroRNA-138 (miR-138) Pseudomonas...
BioCentury | Sep 12, 2013
Tools & Techniques

Molecular biocontainment for the flu

A team from the Icahn School of Medicine at Mount Sinai and the University of Maryland, College Park has engineered a flu virus that is transmissible among ferrets but not humans. 1 The microRNA-based containment...
BioCentury | Apr 14, 2011
Distillery Therapeutics

Indication: Musculoskeletal disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis MicroRNA-138 (miR-138) In vitro and...
Items per page:
1 - 3 of 3